John E. Schneider is the CEO and founder of Avalon Health Economics. His PhD is in Health Services and Policy Analysis from the University of California Berkeley, with a concentration in health economics. He has over 30 years of experience studying economic and organizational aspects of the health care industry. Dr. Schneider’s expertise includes: economic evaluation of new pharmaceuticals, devices, and diagnostics; pricing and reimbursement; analysis of medical care costs; health insurance & managed care; regulation, hospital competition, and health care markets; specialty hospitals; physician ownership; contracting; antitrust; and trademark infringement.
Cara Scheibling is a Director and Principal at Avalon Health Economics. She has her MBA from the University of Tennessee. In addition to business management and development, her focus is on cost analysis and economic valuation. With more than 10 years of experience in health economics, she has developed expertise in developing cost estimates for economic models of pharmaceuticals and medical devices, developing unit cost measures for model adaptations, and estimating reasonable costs of medical services in a variety of health care litigation applications.
With special thanks to
An application for one (1.0) CLE credit has been submitted to the Idaho State Bar.
© 2025 Idaho Association of Defense Counsel
ã Idaho Association of Defense Counsel, Inc. All rights reserved.
